Pacira Biosciences Inc
NASDAQ:PCRX
Pacira Biosciences Inc
NASDAQ:PCRX
Price:
22.88
USD
-1.84%
Market Closed
Market Cap:
$926.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Pacira Biosciences Inc
NASDAQ:PCRX
|
US |
|
Vinda International Holdings Ltd
HKEX:3331
|
HK |
|
A
|
AGBA Group Holding Ltd
F:D6D
|
HK |
|
K
|
Komputronik SA w restrukturyzacji
WSE:KOM
|
PL |
|
S
|
San Miguel Corp
OTC:SMGBF
|
PH |
|
S
|
Silla Co Ltd
KRX:004970
|
KR |
|
K
|
Krynica Vitamin SA
WSE:KVT
|
PL |
|
Zurich Insurance Group AG
LSE:0QP2
|
CH |
|
P
|
Power Solution Technologies PCL
SET:PSTC
|
TH |
|
L
|
Luzerner Kantonalbank AG
SIX:LUKN
|
CH |
|
Lovesac Co
NASDAQ:LOVE
|
US |
|
SICO Saudi REIT Fund
SAU:4337
|
SA |
|
W
|
Wuxi Hodgen Technology Co Ltd
SZSE:300279
|
CN |
|
S
|
SIK Cheong Bhd
KLSE:SCB
|
MY |
|
S
|
Sabien Technology Group PLC
LSE:SNT
|
UK |
|
Hong Leong Bank Bhd
KLSE:HLBANK
|
MY |
|
A
|
AVIC Electromechanical Systems Co Ltd
SZSE:002013
|
CN |
|
Premier Explosives Ltd
NSE:PREMEXPLN
|
IN |
|
GOME Retail Holdings Ltd
HKEX:493
|
CN |
|
Canadian Apartment Properties Real Estate Investment Trust
TSX:CAR.UN
|
CA |
|
Unicasa Industria de Moveis SA
BOVESPA:UCAS3
|
BR |
|
P
|
Pruksa Holding PCL
SET:PSH
|
TH |
Multiples-Based Value
The Multiples-Based Value of one
PCRX
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 22.88 USD,
Pacira Biosciences Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PCRX Multiples-Based Value
LOCKED
Multiples Across Competitors
PCRX Competitors Multiples
Pacira Biosciences Inc Competitors
Pacira Biosciences Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Pacira Biosciences Inc
NASDAQ:PCRX
|
940.8m USD | 1.3 | 134.8 | 8.2 | 27.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD | 12.7 | 40.2 | 27.2 | 29 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.5 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD | 4.6 | 16.2 | 10 | 12.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF | 5.2 | 21.1 | 13 | 16.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.5B GBP | 5.1 | 29.1 | 16.1 | 22.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 9.8 | 7.3 | 8.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD | 2.4 | 16.7 | 7.1 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
